Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H15N3O |
| Molecular Weight | 181.2349 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1CCC2=C(CC1)N=C(N)O2
InChI
InChIKey=ZNXAJGZPUQOEDZ-UHFFFAOYSA-N
InChI=1S/C9H15N3O/c1-2-12-5-3-7-8(4-6-12)13-9(10)11-7/h2-6H2,1H3,(H2,10,11)
Azepexole (or previously known as B-HT 933), a selective alpha 2-adrenoceptor agonist that was studied for the man with physiological tremor. It was shown that the drug produced sedation compared to placebo but not when compared to pre-treatment values. Some studies also have revealed the anti-tussive and antihypertensive properties of azepexole.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats. | 2009-08-15 |
|
| Studies on the protective effect of azepexole on ouabain-induced cardiac arrhythmias and lethality in guinea-pig. | 1995-04-04 |
|
| Antagonistic effects of S9871 or (imidazolinyl-2)-2-dihydro 2,3 benzofurane and its stereoisomers on some central and peripheral actions of alpha 2-agonists. | 1985-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2866788
azepexole 10 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB05651MIG
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
100000086101
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
36067-73-9
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
2277
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
C72919
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
4338
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
C015603
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
DGB112538O
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL149616
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY | |||
|
DTXSID1048419
Created by
admin on Wed Apr 02 08:20:11 GMT 2025 , Edited by admin on Wed Apr 02 08:20:11 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)